There are 3162 resources available
LBA59 - Modified FOLFOX plus/minus nivolumab and ipilimumab vs FLOT plus nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Final results of the IKF-AIO-Moonlight trial
Presenter: Sylvie Lorenzen
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
Tumour antigens derived from bacteria
Presenter: Maria Rescigno
Session: Exploiting the microbiome to improve treatment outcomes
Resources:
Webcast
867MO - Epigenetic therapy modulates the tumor microenvironment to sensitize anti-PD-1 refractory head and neck cancers to immunotherapy
Presenter: Austin Mattox
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Improving anti-tumour immunity with engineered bacteria
Presenter: Jan Theys
Session: Exploiting the microbiome to improve treatment outcomes
Resources:
Slides
Webcast
Assessing patient fitness for treatment of gliomas
Presenter: Julia Furtner
Session: Common clinical problems in neuro-oncology
Resources:
Slides
Webcast
Biomarkers for mCRPC: To test or not to test
Presenter: Elena Castro
Session: POWG 1: Biomarkers in everyday clinical practice
Resources:
Slides
Webcast
Invited Discussant LBA52 and LBA53
Presenter: Marina Garassino
Session: Proffered paper session: NSCLC metastatic
Resources:
Slides
Webcast
Invited Discussant LBA58 and LBA59
Presenter: Tania Fleitas
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Slides
Webcast
How to manage patients with durable response on systemic therapy? Optimal therapy duration and role de-escalation?
Presenter: Debbie Robbrecht
Session: Addressing uncertainties in the management of urothelial and renal cell carcinomas
Resources:
Slides
Webcast
Whole genome sequencing: What are the benefits?
Presenter: Charlie Gourley
Session: Gynaecological cancer: How can technology help the fight?
Resources:
Slides
Webcast